课题基金 / 基金详情

Center for comprehensive proteogenomic data analysis

Center for comprehensive proteogenomic data analysis
综合蛋白质组数据分析中心
批准号:
10644013
负责人:
GAD A GETZ
金额:
$77.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-15 至 2027-05-31
关键词:
AffectAffinityAlgorithmic AnalysisAlgorithmsAntigen TargetingBig DataBiochemicalBioinformaticsBiologicalBiological ModelsCancer BiologyClinicalCollaborationsCollectionComplexComputational BiologyCopy Number PolymorphismDataData AnalysesData CommonsData SetDatabasesDecision AidDecision MakingDifferentiation AntigensDiseaseDoseDrug TargetingDrug resistanceEncapsulatedFoundationsGenesGeneticGenomeGenomicsHLA AntigensHumanImmuneIndividualLeadershipLigaseMalignant NeoplasmsMapsMass Spectrum AnalysisMeasurementMethodologyMethodsModelingMultiomic DataMutateMutationPathway AnalysisPathway interactionsPeptidesPharmaceutical PreparationsPharmacotherapyPhasePhosphotransferasesPost Translational Modification AnalysisPost-Translational Modification SitePost-Translational Protein ProcessingProcessPrognostic MarkerProteinsProteomeProteomicsPublicationsRNAReportingReproducibilityRetrievalSamplingScientistSignal TransductionSiteSourceSpecific qualifier valueStandardizationSubgroupSystemSystems BiologyTechniquesTherapeuticTherapeutic InterventionTissuesTranscriptTranslational ResearchValidationantigen bindingcancer biomarkerscancer subtypescancer typecloud basedcohortcomputerized data processingdata repositorydifferential expressionflexibilitygenomic dataimprovedindividual patientinsightinterestlaboratory experimentmetabolomicsmultiple omicsneoantigensnew therapeutic targetnext generation sequencingnovelpersonalized medicinephenotypic dataproteogenomicsresponsetherapeutic targettooltranscriptomicstranslational pipelinetumorubiquitin isopeptidase

项目摘要

项目成果

GAD A GETZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Proteogenomics involves the integrative multi-omic analysis of genomic, transcriptomic, proteomic and post- translational modification data produced by next-generation sequencing and mass spectrometry-based proteomics. Several publications by the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and others have highlighted the impact of proteogenomics in enabling deeper insight into the biology of cancer and identification of potential drug targets. Integrative analysis of multi-omic data requires the deployment of complex algorithms and data processing techniques, which are generally inaccessible to scientists without a background in bioinformatics and computational biology. Our proposed center for comprehensive proteogenomic data analysis will encapsulate a comprehensive set of analysis methods in a platform that will be (i) simple to use (ii) flexible (iii) automated, facilitating the routine application to all CPTAC proteogenomic datasets as they become available, and (iv) able to incorporate new methods with minimal effort. We will leverage PANOPLY--a cloud-based platform for automated and reproducible proteogenomic data analysis--as the foundation, with specific, carefully chosen algorithms targeted for addition to provide an expansive set of analysis capabilities that can be easily harnessed to provide a rapid and extensive baseline analysis for proteogenomic studies, leading to many disease specific hypotheses that can be explored further using additional computational and wet-lab experiments. Our collection of tools, algorithms and interactive reports will enable unprecedented, automated and integrative systems-biology level analyses of proteome, post-translational modification and metabolomic data combined with genomic data for individual disease cohorts and pan-cancer analysis across cohorts, leading to deeper understanding of cancer biology and enabling identification of therapeutic targets and disease/prognostic biomarkers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center for comprehensive proteogenomic data analysis
  • 批准号:
    10440579
  • 项目类别:
  • 资助金额:
    $79.11万
  • 财政年份:
    2022
  • 负责人:
    GAD A GETZ
  • 依托单位:
Comprehensive analysis of point mutations in cancer
  • 批准号:
    10301857
  • 项目类别:
  • 资助金额:
    $41.83万
  • 财政年份:
    2021
  • 负责人:
    GAD A GETZ
  • 依托单位:
Comprehensive analysis of point mutations in cancer
  • 批准号:
    10491092
  • 项目类别:
  • 资助金额:
    $39.5万
  • 财政年份:
    2021
  • 负责人:
    GAD A GETZ
  • 依托单位:
Comprehensive analysis of point mutations in cancer
  • 批准号:
    10676830
  • 项目类别:
  • 资助金额:
    $39.22万
  • 财政年份:
    2021
  • 负责人:
    GAD A GETZ
  • 依托单位:
海外基金